METHODS TO INCREASE PERMEABILITY OF CORNEAL EPITHELIUM AND DESTABILIZE STROMAL COLLAGEN FIBRIL NETWORK
    1.
    发明申请
    METHODS TO INCREASE PERMEABILITY OF CORNEAL EPITHELIUM AND DESTABILIZE STROMAL COLLAGEN FIBRIL NETWORK 审中-公开
    方法提高角膜上皮细胞的渗透性,并减少粘膜胶原纤维网络

    公开(公告)号:US20110086802A1

    公开(公告)日:2011-04-14

    申请号:US12934310

    申请日:2009-03-18

    摘要: Methods of increasing the permeability of corneal epithelium to facilitate the diffusion of agents into the collagen fibrillar network of the stroma are provided. Used in combination, these methods open the epithelium to facilitate diffusion of stabilization molecules into the stroma and dissociate bridging molecules from stromal collagen fibers, thereby priming the collagen fibrillar network for restabilization by stabilization molecules. These methods can be used to increase the effectiveness and longevity of non-invasive corneal reshaping, such as orthokeratology, for correcting myopia, hyperopia and astigmatism.

    摘要翻译: 提供了增加角膜上皮的渗透性以促进试剂扩散到基质的胶原原纤维网中的方法。 组合使用,这些方法打开上皮,以促进稳定分子扩散到基质中,并将桥接分子从基质胶原纤维解离,从而引发胶原纤维网络,以通过稳定分子进行再稳定化。 这些方法可用于增加非侵入性角膜重塑(如角膜矫正术)矫正近视,远视和散光的有效性和寿命。

    ANTI-INFLAMMATORY ACTIVITY OF EGGSHELL MEMBRANE AND PROCESSED EGGSHELL MEMBRANE PREPARATIONS
    4.
    发明申请
    ANTI-INFLAMMATORY ACTIVITY OF EGGSHELL MEMBRANE AND PROCESSED EGGSHELL MEMBRANE PREPARATIONS 有权
    蛋壳膜和加工的蛋壳膜制备的抗炎活性

    公开(公告)号:US20070178170A1

    公开(公告)日:2007-08-02

    申请号:US11683268

    申请日:2007-03-07

    IPC分类号: A61K35/54

    CPC分类号: A61K35/57

    摘要: The present invention relates to anti-inflammatory activity of eggshell membrane, processed eggshell membrane preparations and eggshell membrane isolates. The invention is directed to eggshell membrane compositions exhibiting anti-inflammatory activity as measured by effects on down-regulating pro-inflammatory plasma antigens in mammals that had orally ingested such compositions. This information supports the potential benefits from administration of naturally occurring material found in eggshell membrane, processed eggshell membrane, eggshell membrane isolates and combinations to reduce pain and inflammation associated with arthritis and other inflammatory conditions.

    摘要翻译: 本发明涉及蛋壳膜,加工蛋壳膜制剂和蛋壳膜分离物的抗炎活性。 本发明涉及通过对口服摄取这种组合物的哺乳动物中的下调促炎血浆抗原的作用测量显示抗炎活性的蛋壳膜组合物。 该信息支持从蛋壳膜,加工的蛋壳膜,蛋壳膜分离物和组合中发现的天然存在的材料的管理的潜在益处,以减少与关节炎和其他炎性病症相关的疼痛和炎症。

    Methods for accelerated orthokeratology
    5.
    发明授权
    Methods for accelerated orthokeratology 失效
    加速矫形术的方法

    公开(公告)号:US6161544A

    公开(公告)日:2000-12-19

    申请号:US14955

    申请日:1998-01-28

    摘要: An accelerated method of orthokeratology includes the steps of softening of the cornea with a softening agent, applying a mold to reshape the cornea to a desired anterior curvature, and rapidly restabilizing or "fixing" the corneal tissues so that the cornea retains its new configuration. A chemical softening agent, such as glutaric anhydride is applied to the cornea to soften the cornea, after which a specially designed mold of predetermined curvature and configuration is applied to the cornea. Slight downward pressure is applied to the mold for a predetermined period of time to re-shape the cornea. The mold is maintained in position while a stabilizing agent, such as a UV light source, is positioned above the mold. The stabilizing agent, i.e. UV light, is applied to the cornea for a predetermined time, wherein the stabilizing agent immediately restabilizes the corneal tissue so that the cornea immediately retains its shape upon removal of the mold. The stabilization process can also be used for patients having already undergone traditional orthokeratology to eliminate the need to continue wearing a retainer to maintain the shape of the cornea.

    摘要翻译: 一种加速矫形术的方法包括用软化剂软化角膜的步骤,应用模具将角膜重新形成期望的前曲率,并且快速地恢复或“固定”角膜组织,使得角膜保持其新的构型。 向角膜施加化学软化剂如戊二酸酐以软化角膜,之后将具有预定曲率和构型的专门设计的模具应用于角膜。 向模具施加稍微向下的压力一段预定的时间以重新形成角膜。 模具保持在适当的位置,而诸如UV光源的稳定剂位于模具上方。 将稳定剂即UV光施加到角膜预定时间,其中稳定剂立即使角膜组织恢复稳定,使得角膜在移除模具时立即保持其形状。 稳定过程也可以用于已经经历了传统角膜曲率学的患者,以消除继续佩戴保持器以维持角膜的形状的需要。

    ULTRAVIOLET IRRADIATION TO TREAT CORNEAL WEAKNESS DISORDERS
    6.
    发明申请
    ULTRAVIOLET IRRADIATION TO TREAT CORNEAL WEAKNESS DISORDERS 审中-公开
    紫外线辐射治疗恶性恶性肿瘤

    公开(公告)号:US20110060267A1

    公开(公告)日:2011-03-10

    申请号:US12922424

    申请日:2009-03-10

    IPC分类号: A61F9/00

    摘要: Methods of strengthening the biomechanical properties of the cornea by exposing the cornea to ultraviolet light in the presence of a photoinitiator are described. These methods can be used to treat keratoconus. They can also be used to treat ectasia following a surgical procedure, or to strengthen the cornea prior to a surgical procedure.

    摘要翻译: 描述了通过在光引发剂的存在下将角膜暴露于紫外光来增强角膜的生物力学性质的方法。 这些方法可用于治疗圆锥角膜。 它们也可用于治疗外科手术后的扩张,或在外科手术之前加强角膜。

    Methods for stabilizing corneal tissue
    7.
    发明申请
    Methods for stabilizing corneal tissue 审中-公开
    稳定角膜组织的方法

    公开(公告)号:US20090105127A1

    公开(公告)日:2009-04-23

    申请号:US12285683

    申请日:2008-10-10

    IPC分类号: A61K38/16

    摘要: Methods of stabilizing collagen fibrils in a cornea are disclosed. The stabilization may be effected by treating the cornea with a protein that crosslinks collagen fibrils, such as decorin. The stablization methods include treatment of corneas before, during, or after a surgical procedure, treatment of keratectasia, and treatment of keratoconus.

    摘要翻译: 公开了在角膜中稳定胶原原纤维的方法。 可以通过用交联胶原原纤维的蛋白质(例如核心蛋白聚糖)处理角膜来实现稳定化。 稳定方法包括在外科手术之前,期间或之后治疗角膜,治疗角膜炎,以及治疗圆锥角膜。

    Methods and Therapies for Treating Inflammatory Conditions with Exposed Collagen
    8.
    发明申请
    Methods and Therapies for Treating Inflammatory Conditions with Exposed Collagen 有权
    用暴露胶原治疗炎症病症的方法和疗法

    公开(公告)号:US20070071676A1

    公开(公告)日:2007-03-29

    申请号:US11534847

    申请日:2006-09-25

    IPC分类号: A61K51/00

    摘要: Compositions and methods for treating and imaging vulnerable plaque and other inflammatory conditions in a patient rely on the delivery of conversion electron-emitting sources and other radionuclides to regions of exposed collagen in the vasculature or other body lumens. The conversion electron-emitting sources or other radionuclides are coupled to a collagen-binding substance and administered to the vasculature or other body lumen to permit binding for imaging and/or therapeutic purposes.

    摘要翻译: 用于治疗和成像患者易损斑块和其他炎性病症的组合物和方法依赖于将转化的电子发射源和其它放射性核素递送到脉管系统或其他体腔内暴露胶原的区域。 转换电子发射源或其他放射性核素与胶原结合物质偶联,并施用于脉管系统或其他体腔,以允许用于成像和/或治疗目的的结合。

    Chemical treatment of in vivo tissue to alter charge and net charge density characteristics
    9.
    发明申请
    Chemical treatment of in vivo tissue to alter charge and net charge density characteristics 审中-公开
    化学处理体内组织以改变电荷和净电荷密度特征

    公开(公告)号:US20050106270A1

    公开(公告)日:2005-05-19

    申请号:US10959740

    申请日:2004-10-06

    IPC分类号: A61K33/00

    CPC分类号: A61K33/00

    摘要: A method for treating animal tissue with acylation agents to alter the net charge and net charge density of the treated tissue for therapeutic applications is provided. The method involves applying an alkaline solution to the exposed tissue surface area. This results in deprotonation of ε-amino groups of lysine residues on the exposed tissue proteins so that the tissue proteins have a net charge. Then, an acylating agent is applied and the acylating agent reacts with the tissue protein to form a protein complex having an altered net charge. Acylating agents such as sulfonic acids, sulfonyl chlorides, and acid chlorides can be used. The method can be used to treat a wide variety of human tissues including the human cornea for correcting myopia. The method can also be used to treat skin tissue, so that there is an increase in dermal thickness and pliability. The method can be further used to treat articular cartilage.

    摘要翻译: 提供了一种用酰化剂处理动物组织以改变用于治疗应用的经处理组织的净电荷和净电荷密度的方法。 该方法包括向暴露的组织表面区域施加碱性溶液。 这导致在暴露的组织蛋白上赖氨酸残基的ε-氨基的去质子化,使得组织蛋白质具有净电荷。 然后,施加酰化剂,并且酰化剂与组织蛋白质反应形成具有改变的净电荷的蛋白质复合物。 可以使用酰化剂如磺酸,磺酰氯和酰氯。 该方法可用于治疗各种人体组织,包括用于矫正近视的人角膜。 该方法也可用于治疗皮肤组织,使真皮厚度和柔韧性增加。 该方法可以进一步用于治疗关节软骨。

    Implantation Compositions for Use in Tissue Augmentation
    10.
    发明申请
    Implantation Compositions for Use in Tissue Augmentation 审中-公开
    用于组织增强的植入组合物

    公开(公告)号:US20100041788A1

    公开(公告)日:2010-02-18

    申请号:US12521947

    申请日:2007-07-31

    IPC分类号: A61F2/00

    摘要: A composition of matter and method for preparation of a tissue augmentation material. A polysaccharide gel composition is prepared with rheological properties selected for a particular selected application. The method includes preparing a polymeric polysaccharide in a buffer to create a polymer solution or gel suspending properties in the gel and selecting a rheology profile for the desired tissue region.

    摘要翻译: 用于制备组织增强材料的物质组合物和方法。 制备具有针对特定选定应用选择的流变性质的多糖凝胶组合物。 该方法包括在缓冲液中制备聚合多糖以产生凝胶中的聚合物溶液或凝胶悬浮性质并选择所需组织区域的流变学特性。